Cell-mediated immunity and head and neck cancer: With special emphasis on betel quid chewing habit

Oral Oncology

Volumn 41, Issue 8, 2005, Pages 757-775

  Chang, M C ^a   Chiang, C P ^b   Lin, C L ^b   Lee, J J ^b   Hahn, L J ^b   Jeng, J H ^b  

^a CHANG GUNG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Betel quid chewing; Cell mediated immunity; Head and neck cancer; Oral cancer; Oral submucous fibrosis

Indexed keywords

ALCOHOL; DNA; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 6; INTERLEUKIN 8; LIPID; PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ALCOHOL CONSUMPTION; APOPTOSIS; BETEL NUT; CELL COUNT; CELLULAR IMMUNITY; CHEMOPROPHYLAXIS; CYTOKINE PRODUCTION; DNA STRUCTURE; DOWN REGULATION; ENVIRONMENTAL EXPOSURE; GENOTOXICITY; HEAD AND NECK CARCINOMA; HUMAN; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; IMMUNOLOGICAL TOLERANCE; IMMUNOPATHOGENESIS; IMMUNOSURVEILLANCE; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; KERATINOCYTE; LEUKOPLAKIA; LYMPHOCYTE; LYMPHOCYTOPOIESIS; MAJOR HISTOCOMPATIBILITY COMPLEX; MASTICATION; MONONUCLEAR CELL; MOUTH CARCINOMA; MOUTH DISEASE; PRIORITY JOURNAL; PROSTAGLANDIN BLOOD LEVEL; REDUCTION; REVIEW; SUPPRESSOR CELL; TUMOR ASSOCIATED LEUKOCYTE; TUMOR CELL;

ARECA; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNITY, CELLULAR; LYMPHOCYTE SUBSETS; LYMPHOCYTES, TUMOR-INFILTRATING; MASTICATION; ORAL SUBMUCOUS FIBROSIS;

EID: 23744456158     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2005.01.007     Document Type: Review

References (155)

1. P.B. Desai Clinical cancer research in India: present status and future prospects Indian J Med Res 78 1983 8 28
2. DOH Report, Department of Health, Taiwan, Republic of China, Cancer Registration Report;2003.
3. A. Znaor, P. Brennan, V. Gajalakshmi, A. Mathew, V. Shanta, and C. Varghese Independent and combined effects of tobacco smoking, chewing and alcohol drinking on the risk of oral, pharyngeal and esophageal cancers in Indian men Int J Cancer 105 2003 681 686
4. Y.C. Ko, Y.L. Huang, C.H. Lee, M.C. Chen, L.M. Lin, and C.C. Tsai Betel quid chewing, cigarette smoking and alcohol consumption related to oral cancer in Taiwan J Oral Pathol Med 24 1995 450 453
5. B.B. Yeole, A.V. Ramanakumar, and R. Sankaranarayanan Survival from oral cancer in Mumbai (Bombay), India Cancer Causes Control 14 2003 945 952
6. C.H. Lee, Y.C. Ko, H.L. Huang, Y.Y. Chai, C.C. Tsai, and T.Y. Shieh The precancer risk of betel quid chewing, tobacco use and alcohol consumption in oral leukoplakia and oral submucous fibrosis in southern Taiwan Br J Cancer 88 2003 366 372
7. J.J. Pindborg Oral cancer and precancer 1980 John Wright Bristol p. 108-11
8. S. Warnakulasuriya Semi-quantitative clinical description of oral submucous fibrosis Ann Dent 46 1987 18 21
9. R. Maher, A.J. Lee, K.A.A.S. Warnakulasuriya, J.A. Lewis, and N.W. Johnson Role of areca nut in the causation of oral submucous fibrosis: a case-control study in Pakistan J Oral Pathol Med 23 1994 65 69
10. P.R. Murti, R.B. Bhonsle, P.C. Gupta, D.K. Daftary, J.J. Pindborg, and F.S. Mehta Etiology of oral submucous fibrosis with special reference to the role of areca nut chewing J Oral Pathol Med 24 1995 145 152
11. N. Shah, and P.P. Sharma Role of chewing and smoking habits in the etiology of oral submucous fibrosis (OSF): a case-control study J Oral Pathol Med 27 1998 475 479
12. H.M. Chen, C.Y. Wang, C.T. Chen, H. Yang, Y.S. Kuo, and W.H. Lan Autofluorescence spectra of oral submucous fibrosis J Oral Pathol Med 32 2003 337 343
13. H.M. Chen, R.P. Hsieh, H. Yang, Y.S. Kuo, M.Y.P. Kuo, and C.P. Chiang HLA typing in Taiwanese patients with oral submucous fibrosis J Oral Pathol Med 33 2004 191 199
14. C.P. Chiang, R.P. Hsieh, T.H. Chen, Y.F. Chang, B.Y. Liu, and J.T. Wang High incidence of autoantibodies in Taiwanese patients with oral submucous fibrosis J Oral Pathol Med 31 2002 402 409
15. C.P. Chiang, H.Y. Wu, B.Y. Liu, J.T. Wang, and M.Y.P. Kuo Quantitative analysis of immunocompetent cells in oral submucous fibrosis in Taiwan Oral Oncol. 38 2002 56 63
16. N.M. Boyd, and P.C. Reade Mechanisms of carcinogenesis with particular reference to the oral mucosa J. Oral Pathol. 17 1988 193 201
17. J.H. Jeng, M.C. Chang, and L.J. Hahn Role of areca nut in betel quid-associated chemical carcinogenesis: current awareness and future perspectives Oral Oncol. 37 2001 477 492
18. IARC. IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans, vol. 37;1985. Lyon: International Agency for Research on Cancer.
19. J.K. Adam, B. Odhav, and K.D. Bhoola Immune responses in cancer Pharmacol Ther 99 2003 113 132
20. D. Pardoll Does the immune system see tumors as foreign or self? Annu Rev Immunol 21 2003 807 839
21. M. Jakobisiak, W. Lasek, and J. Golab Natural mechanisms protecting against cancer Immunol Lett 90 2003 103 122
22. T. Vijaykumar, K.R. Shanavas, and D.M. Vasudevan Immunological phenomenon in human oral carcinoma in India Oral Oncol Eur J Cancer 29B 1993 181 185
23. D.W. Thomas, J.B. Matthews, V. Patel, S.M. Game, and S.S. Prime Inflammatory cell infiltrate associated with primary and transplantated tumours in an inbred model of oral carcinogenesis J Oral Pathol Med 24 1995 23 31
24. K. Kumpawat, S. Deb, S. Ray, and A. Chatterjee Genotoxic effect of raw betel-nut extract in relation to endogenous glutathione levels and its mechanism of action in mammalian cells Mutat Res 538 2003 1 12
25. A. Chatterjee, and S. Deb Genotoxic effect of arecoline given either by the peritoneal or oral route in murine bone marrow cells and the influence of N-acetylcysteine Cancer Lett 139 1999 23 31
26. J.H. Jeng, Y.S. Ho, C.P. Chan, Y.J. Wang, L.J. Hahn, and D. Lei Areca nut extract up-regulates prostaglandin production, cyclooxygenase-2 mRNA and protein expression of human oral keratinocytes Carcinogenesis. 21 2000 1365 1370
27. J.H. Jeng, Y.J. Wang, B.L. Chiang, Ph. Lee, C.P. Chan, and Y.S. Ho Roles of keratinocyte inflammation in oral cancer: regulating the prostaglandin E2, interleukin-6 and TNF-alpha production of oral epithelial cells by areca nut extract and arecoline Carcinogenesis. 24 2003 1301 1315
28. S.M. Sirsat, and J.J. Pindborg Subepithelial changes in oral submucous fibrosis Acta Pathol Microbiol Scand J 70 1967 161 173
29. R. Rajendran Oral submucous fibrosis J Oral Maxillofac Pathol 7 2003 1 4
30. M.F. Haque, M. Harris, S. Meghji, and P.M. Speight An immunohistochemical study of oral submucous fibrosis J Oral Pathol Med 26 1997 75 82
31. S.C. Cox, and D.M. Walker Oral submucous fibrosis. A review Aust Dent J 41 1996 294 299
32. M.J. Embleton, and R.W. Baldwin Antigenic changes in chemical carcinogenesis Br Med Bull 36 1980 83 88
33. G. Pawelec Immunotherapy and immunoselection-tumour escape as the final hurdle FEES Lett 567 2004 63 66
34. M.J. Turk, J.D. Wolchok, J.A. Guevara-Patino, S.M. Goldberg, and A.N. Houghton Multiple pathways to tumor immunity and concomitant autoimmunity Immunol Rev 188 2002 122 135
35. U.J. Nair, M. Friesen, I. Richard, R. Maclennan, S. Thomas, and H. Bartsch Effect of lime composition on the formation of reactive oxygen species from areca nut extract in vitro Carcinogenesis. 11 1990 2145 2148
36. C.L. Chen, C.W. Chi, K.W. Chang, and T.Y. Liu Safrole-like DNA adducts in oral tissue from oral cancer patients with a betel quid chewing history Carcinogenesis. 20 1999 2331 2334
37. H. Bartsch, M. Rojas, U. Nair, J. Nair, and K. Alexandrov Genetic cancer susceptibility and DNA adducts: studies in smokers, tobacco chewers and coke oven workers Cancer Detect Prev 23 1999 445 453
38. N. Weliky, and D.C. Heiner A common pathway for chemical-induced tissue injury and immune responses leading to hypersensitivity and/or carcinogenesis Med Hypoth 16 1985 69 91
39. G.T. Wolf, S. Schmaltz, J. Hudson, and H. Robson Alterations in T-lymphocyte subpopulations in patients with head and neck cancer. Correlation with prognosis Arch Otolaryngol Head Neck Surg 113 1987 1200 1206
40. B.P. O'Connor, M.W. Gleeson, R.J. Noelle, and L.D. Erickson The rise and fall of long-lived humoral immunity: terminal differentiation of plasma cells in health and disease Immunol Rev 194 2003 61 76
41. N.T. Berlinger, E.Y. Hilal, H.F. Oettgen, and R.A. Good Deficient cell-mediated immunity in head and neck cancer patients secondary to autologous suppressor immune cells Laryngoscope. 88 1978 470 483
42. G.W. Hubbard, H. Wanebo, M. Fukuda, and R. Pace Defective suppressor cell activity in cancer patients Cancer. 47 1981 2177 2184
43. K.J. O'Byrne, A.G. Dalgleish, M.J. Browning, W.P. Steward, and A.L. Harris The relationship between angiogenesis and the immune response in carcinogenesis and the progression of malignant disease Eur J Cancer 36 2000 151 169
44. M.J. Smyth, Y. Hayakawa, K. Takeda, and H. Yagita New aspects of natural-killer-cell surveillance and therapy of cancer Nature Rev Cancer 2 2002 850 861
45. H.K. Muller, G.W. Dandie, S.J. Ragg, and G.M. Woods Langerhans cell alterations in cutaneous carcinogenesis In Vivo 7 1993 293 296
46. K. Kurihara, and N. Hashimoto The pathological significance of Langerhans cells in oral cancer J Oral Pathol 14 1985 289 298
47. A.M. Woltman, and C. Van Kooten Functional modulation of dendritic cells to suppress adaptive immune responses J Leukocyte Biol 73 2003 428 441
48. A. Gallimore, and S. Sakaguchi Regulation of tumor immunity of CD25+ T cells Immunology. 107 2002 5 9
49. R. Dammer, E.M. Wurm, H. Niederdellmann, H. Fleishmann, and R. Knuchel Immunocytochemical venous blood studies in patients with manifest oral cavity carcinomas, oral precancerous conditions, benign tumors and in chronic alcoholic patients Mund Kiefer Gesichtscher 1 1997 95 103
50. D.P. Eskinazi, J.J. Perna, and R. Mihail Mononuclear cell subsets in patients with oral cancer Cancer. 60 1987 376 381
51. M. Strome, J.R. Clark, M.P. Fried, S. Rodliff, and B.A. Blazar T-cell subsets and natural killer cell function with squamous cell carcinoma of the head and neck Arch Otolaryngol Head Neck Surg 113 1987 1090 1093
52. J. Bier, U. Nicklisch, and H. Platz The doubtful relevance of nonspecific immune reactivity in patients with squamous cell carcinoma of the head and neck region Cancer. 52 1983 1165 1172
53. R.J. Eastham, J.M. Mason, B.R. Jenning, P.W. Belew, and T.A. Maguda T-cell rosette test in squamous cell carcinoma of the head and neck Arch Otolaryngol 102 1976 171 175
54. S.S. Stefani, and R.H. Kerman Lymphocyte response to PHA before and after radication therapy in patients with carcinoma of the head and neck J Laryngol Otol 91 1977 605 609
55. H.J. Wanebo, M.Y. Jun, E.W. Strong, and H. Oettgen T-cell deficiency in patients with squamous cell cancer of head and neck Am J Surg 130 1975 445 451
56. J. Johnson, B. Rabin, B. Hirsch, and P. Thearle T cell subpopulations in head and neck carcinoma Otolaryngol Head Neck Surg 92 1984 381 385
57. I. Kuss, T. Saito, J.T. Johnson, and T.L. Whiteside Clinical significance of decreased ζ chain expression in peripheral blood lymphocytes of patients with head and neck cancer Clin Cancer Res 5 1999 329 334
58. I. Kuss, B. Hathaway, R.L. Ferris, W. Gooding, and T.L. Whiteside Decreased absolute counts of T lymphocyte subsets and their relation to disease in squamous cell carcinoma of the head and neck Clin Cacner Res 10 2004 3755 3762
59. M.R. Pillai, P. Balaram, T. Abraham, and M.K. Nair Lymphocyte populations in premalignant lesions and cancer of the oral cavity Neoplasma. 34 1987 469 479
60. R.J. Tatake, N. Krishnan, R.S. Rao, A.R. Fakih, and S.G. Gangal Lymphokine-activated killer-cell function of lymphocytes from peripheral blood, regional lymph nodes and tumor tissues of patients with oral cancer Int J Cancer 43 1989 560 566
61. P. Balaram, and D.M. Vasudevan Quantitation of Fc receptor-bearing T-lymphocytes (Tg and TM) in oral cancer Cancer. 52 1983 1837 1840
62. S.N. Das, N.N. Khanna, and S. Khanna In vivo and in vitro observation of cellular immune parameters in squamous cell carcinoma of the oral cavity and its correlation with tumor load and prognosis Cancer Invest 4 1986 207 216
63. R. Rajendran, C.K. Sugathan, P. Remani, R. Ankathil, and T. Vijayakumar Cell mediated and humoral immune responses in oral submucous fibrosis Cancer. 58 1986 2628 2631
64. T. Vijayakumar, and D.M. Vasudevan High affinity rosette forming cells in carcinoma of oral cavity, uterine cervix and breast Cancer Lett 27 1985 339 345
65. V.K. Sasidharan, T.V. Kumari, T. Vijayakumar, and D.M. Vasudevan Immunological assessment of patients suffering from carcinoma Ind J Radiol Image 39 1989 67 70
66. A. Laad, J. Kode, S. Chavan, R. Rao, A.R. Fakih, and S. Chiplunkar Limiting diluation analysis of proliferating and cytotoxic lymphocytes in the peripheral blood and tumours of oral cancer patients Eur J Cancer Oral Oncol 32B 1996 337 342
67. D. Saranath, R. Mukhopadhyaya, R.S. Rao, A.R. Fakih, S.L. Naik, and S.G. Gangal Cell mediated immune status in patients with squamous cell carcinoma of the oral cavity Cancer. 56 1985 1062 1070
68. R.S. Selvan, M. Salvakumaran, and A.R. Rao Influence of arecoline on immune system: I. Short term effects on general parameters and on the adrenal and lymphoid organs Immunopharmacol Immunotoxicol 11 1989 347 377
69. R.S. Selvan, M. Salvakumaran, and A.R. Rao Influence of arecoline on immune system: II. Suppression of thymus-dependent immune responses and parameter of non-specific resistance after short-term exposure Immunopharmacol Immunotoxicol 13 1991 281 309
70. R.S. Selvan, and A.R. Rao Influence of arecoline on immune system: III. Suppression of B cell-mediated immune response in mice after short-term exposure Immunopharmacol Immunotoxicol 15 1993 291 305
71. R. Ghosh, J.K. Sharma, and P.K. Ghosh Sister chromatid exchanges in the lymphocytes of patients with oral leukoplakia Cancer Genet Cytogenet 36 1988 177 182
72. P.K. Ghosh, R. Madhavi, M. Guntur, and R. Ghosh Sister chromatid exchanges in patients with oral submucous fibrosis Cancer Genet Cytogenet 44 1990 197 201
73. S.S. Desai, S.D. Ghaisas, S.D. Jakhi, and S.V. Bhide Cytogenetic damage in exfoliated oral mucosal cells and circulating lymphocytes of patients suffering from precancerous oral lesions Cancer Lett 109 1996 9 14
74. B.J. Dave, A.H. Trivedi, and S.G. Adhvaryu Role of areca nut consumption in the cause of oral cancers. A cytogenetic assessment Cancer. 70 1992 1017 1023
75. T.Y. Liu, Y.T. Chung, P.F. Wang, C.W. Chi, and L.L. Hsieh Safrole-DNA adducts in human peripheral blood- an association with areca quid chewing and CYP2E1 polymorphisms Mutat Res 559 2004 59 66
76. T. Osaki, T. Kimura, Y. Tatemoto, T. Yamamoto, and K. Yoneda Risk factors of metastasis in oral squamous cell carcinoma Oncology. 58 2000 137 143
77. M. Okamoto, G. Ohe, T. Oshikawa, H. Nishikawa, S. Furuichi, and H. Yoshida Induction of cytokines and killer cell activities by cisplatin and 5-fluorouracil in head and neck cancer patients Anti-cancer Drugs 11 2000 165 173
78. M. Tisch, F. Heimlich, V. Daniel, G. Opelz, and H. Maier Cellular immune defect caused by postsurgical radiation therapy in patients with head and neck cancer Otolaryngol Head Neck Surg 119 1998 412 417
79. W.C. Gray, P.B. Chretien, C.M. Suter, D.R. Revie, V.T. Tomazic, and C.L. Blanchard Effect of radiation therapy on T-lymphocyte subpopulations in patients with head and neck cancer Otolaryngol Head Neck Surg 93 1985 650 659
80. J.H. Heimdal, H.J. Aarstad, B. Klementsen, and J. Olofsson Disease stage related in viro responsiveness of peripheral blood T-lymphocytes in patients with head and neck cancer Acta Otolaryngol 118 1998 887 891
81. C.H. Snyderman, D.S. Heo, J.T. Johnson, F. D'Amico, L. Barnes, and T.L. Whiteside Functional and phenotypic analysis of lymphocytes in head and neck cancer Arch Otolaryngol Head Neck Surg 117 1991 899 905
82. K. Yoneda, T. Yamamoto, E. Ueta, K. Nakao, and T. Osaki Influence of aging and chemoradiotherapy on leucocyte function in oral cancer patients Oral Oncol Eur J Cancer 31B 1995 144 150
83. R.A. Mickel, D.J. Kessler, J.M.G. Taylor, and A. Lichtenstein Natural killer cell cytotoxicity in the peripheral blood, cervical lymph nodes and tumor of head and neck cancer patients Cancer Res 48 1988 5017 5022
84. S.P Schantz, E.J. Shillitoe, B. Brown, and B. Campbell Natural killer cell activity and head and neck cancer: A clinical assessment J Natl Cancer Inst 77 1986 869 875
85. M.R. Pillai, P. Balaram, S. Kannan, L. Sudha, K.R. Nalinakumari, and N.K. Hareendran Interferon activation of latent natural killer cells and alteration in kinetics of target cell lysis: clinical implications for oral precancerous lesions Oral Surg Oral Med Oral Pathol 70 1990 458 461
86. P. Balaran, M.R. Pillai, T. Abraham, K.R. Nalinakumari, G. Meenattoor, and S. Kannan Interferon and interleukin-2 induced spontaneous cell-mediated cytotoxicity: A preliminary evaluation J Cancer Res Clin Oncol 118 1992 408 410
87. A. Agarwal, M. Rani, G.K. Saha, T.M. Valarmathi, S. Bahadur, and B.K. Mohanti Disregulated expression of the Th2 cytokine gene in patients with intraoral squamous cell carcinoma Immunol Invest 32 2003 17 30
88. A.V. Jamkar, M.M. Gore, N. Kedarnath, A.C. Banerjee, Meht, and S.N. Gosh Natural killer cell activity in oral cancer patients. Correlation with tumor size and metastasis in regional lymphy nodes Ind J Cancer 20 1983 49 53
89. P.S. Murali, R. Somasundaram, R.S. Rao, A.R. Fakih, and S.G. Gangal Interleukin-2 mediated regulation of mitogen-activated T cell reactivity from different lymphoid sources in patients with squamous cell carcinoma of the oral cavity J Oral Pathol Med 18 1989 327 332
90. C.A. Migliorati, E.K.J. Migloirati, S. Silverman, D. Greenspan, and J.S. Greenspan Phenotypic identification of mononuclear cells in oral premalignant lesions and cancer by monoclonal antibodies J Oral Pathol 15 1986 352 358
91. C.H Snydermann, D.S. Heo, K. Chen, T.L. Whiteside, and J.T. Johnson T cell markers in tumor infiltrating lymphocytes of head and neck cancer Head Neck Surg 11 1989 331 336
92. T. Loning, H. Broemel, W.M. Becker, and H.F. Otto Identification of inflammatory cell phenotypes in human oral carcinomas by means of monocloncal antibodies Arch Oral Biol 28 1983 1093 1100
93. M. Neuchrist, M. Grasl, O. Scheiner, H. Lassmann, K. Ehrenberger, and D. Kraft Squamous cell carcinoma: infiltrating monocyte/macrophage subpopulations express functional mature phenotype Br J Cancer 62 1990 748 753
94. H. Hiratsuka, M. Imamura, K. Kasai, H. Kamiya, Y. Ishii, and G. Kohama Lymphocyte subpopulations and T-cell subsets in human oral cancer tissues: Immunohistologic analysis by monoclonal antibodies Am J Clin Pathol 81 1984 464 470
95. Y. Harabuchi, N. Yamanaka, and A. Kataura Identification of lymphocyte subsets and natural killer cells in head and neck cancers: an immunohistological study using monoclonal antibodies Arch Otorhinolaryngol 242 1985 89 97
96. J. Hirota, E. Ueta, T. Osaki, and Y. Ogawa Immunohistological study of mononuclear cell infiltrates in oral squamous cell carcinoma Head Neck 12 1990 118 125
97. J.T. Vetto, S. Lum, A. Morris, M. Sicotte, J. Davis, and M. Lemon Presence of the T cell activation marker OX-40 on tumor infiltrating lymphocytes and draining lymph node cells from patients with melanoma and head and neck cancer Am J Surg 174 1997 258 265
98. H.A. Horst, and H. Horny Tumor infiltrating lymphoreticular cells. Histologic and immunohistologic investigations performed on metastasizing squamous cell carcinomas of the head and neck Cancer. 68 1991 2397 2402
99. G. Gannot, I. Gannot, H. Vered, A. Buchner, and Y. Keisari Increase in immune cell infiltration with progression of oral epithelium from hyperkeratosis to dysplasia and carcinoma Br J Cancer 86 2002 1444 1448
100. K. Boheim, H. Denz, C. Boheim, H. Glassl, and H. Huber An immunohistologic study of the distribution and status of activation of head and neck tumor infiltrating leukocytes Arch Otorhinolaryngol 244 1987 127 132
101. J. Timar, C. Forster-Horvath, J. Eukits, B. Dome, A. Ladanyi, and E. Remenar The effect of leukocyte interleukin injection (Multikine) treatment on the peritumoral and intratumoral subpopulation of mononuclear cells and on tumor epithelia: a possible new approach to augmentating sensitivity to radiation therapy and chemotherapy in oral cancer-a multicenter phase I/II clinical trial Laryngoscope. 113 2003 2206 2217
102. M. Mandell-Brown, J.T. Johnson, B.S. Rabin, E. Hamill, and R.L. Wagner Neck node immunoreactivity in head and neck carcinoma Otolaryngol Head Neck Surg 95 1986 500 506
103. T. Tachibana, and K. Yoshida Role of regional lymph node in cancer metastasis Cancer Metast Rev 5 1986 55 66
104. E. Verastegui, R. Marales, J.L. Barrera, A. Mueller, J. Haden, and B. Guzman Immunological approach in the evaluation of regional lymph nodes of patients with squamous cell carcinoma of the head and neck Clin Immunol 102 2002 37 47
105. D.J. Kessker, R.A. Mickel, and A. Lichtenstein Depressed natural killer cell activity in cervical lymph nodes containing focal metastatic squamous cell carcinoma Arch Otolaryngol Head Neck Surg 114 1988 313 318
106. T.L. Whiteside Immunobiology and immunotherapy of head and neck cancer Curr Oncol Rep 3 2001 46 55
107. S.Q.J. Rice, I.J. Crane, C. Scully, and S.S. Prime Production of a suppressor of lymphocyte proliferation by two human oral carcinoma cell lines Scand J Immunol 36 1992 443 452
108. T.P.U. Wustrow, and C.G. Mahnke Causes of immunosuppression in squamous cell carcinoma of the head and neck Anticancer Res 16 1996 2433 2468
109. D. Wang, H. Wang, Q. Shi, S. Katkuri, W. Walhi, and B. Desvergne Prostaglandin E(2) promotes colorectal adenoma growth via transactivation of the nuclear peroxisome proliferator-activated receptor delta Cancer Cell 6 2004 285 295
110. J.R. Benson Role of transforming growth factor beta in breast carcinogenesis Lancet Oncol 5 2004 229 239
111. M.R.I. Young, M.A. Wright, Y. Lozano, J.P. Matthews, J. Benefield, and M.M. Prechel Mechanisms of immune suppression in patients with head and neck cancer: influence on the immune infiltrate of the cancer Int J Cancer 67 1996 333 338
112. L. Muller, R. Kiessling, R. Ress, and G. Pawelec Escape mechanisms in tumor immunity: an update J Environ Pathol Toxicol Oncol 21 2002 277 330
113. G.R. Thomas, Z. Chen, M.N. Oechsli, F.J. Hendler, and C. Van Waes Decreased expression of CD80 is a marker for increased tumorigenicity in a new murine model of oral squamous-cell carcinoma Int J Cancer 82 1999 377 384
114. T.E. Reichart, L. Strauss, E.M. Wagner, W. Gooding, and T.L. Whiteside Signaling abnormalities, apoptosis and reduced proliferation of circulating and tumor infiltrating lymphocytes in patients with oral cancer Clin Cancer Res 8 2002 3137 3145
115. M. Matsui, M. Ikeda, and T. Akatsuka High expression of HLA-A2 on an oral squamous cell carcinoma with down-regulated transporter for antigen presentation Biochem Biophys Res Commun 280 2001 1008 1014
116. A. Garcia-Lora, I. Algarra, and F. Garrido MHC Class I antigens, immune surveillance, and tumor immune escape J Cell Physiol 195 2003 346 355
117. J.A. Yang, S.A. Huber, and Z.J. Lucas Inhibition of DNA synthesis in cultured lymphocytes and tumor cells by extracts of betel nut, tobacco, and miang leaf, plant substances associated with cancer of the ororespiratory epithelium Cancer Res 39 1979 4802 4809
118. M.C. Chang, Y.S. Ho, P.H. Lee, C.P. Chan, J.J. Lee, and L.J. Hahn Areca nut extract and arecoline induced the cell cycle arrest but not apoptosis of cultured oral KB epithelial cells: association of glutathione, reactive oxygen species and mitochondrial membrane potential Carcinogenesis 22 2001 1527 1535
119. H.J. Hsu, K.L. Chang, Y.H. Yang, and T.Y. Shieh The effect of arecoline on the release of cytokines using cultured peripheral blood mononuclear cells from patients with oral mucous diseases Kaohsiung J Med Sci 17 2001 175 182
120. S.L. Hung, Y.L. Chen, H.C. Wan, T.Y Liu, Y.T. Chen, and L.J. Ling Effects of areca nut extracts on the functions of human neutrophils in vitro J Periodont Res 35 2000 186 193
121. G.B. Panigrahi, and A.R. Rao Chromosomal breaking ability of arecoline, a major betel-nut alkaloid, in mouse bone-marrow cells in vivo Mutat Res 103 1982 197 204
122. G.B. Panigrahi, and A.R. Rao Induction of in vivo sister chromatid exchange by arecaidine, a betel nut alkaloid, in mouse bone marrow cells Cancer Lett 23 1984 189 192
123. G.B. Panigrahi, and A.R. Rao Study of the genotoxicity of the total aqueous extract of betel nut and its tannin Carcinogenesis. 7 1986 37 39
124. J.R. Saikia, F.H. Schneeweiss, and R.N. Sharan Arecoline-induced changes of poly-Adp-ribosylation of cellular proteins and its influence on chromatin organization Cancer Lett 139 1999 59 65
125. F.R. Althaus Poly ADP-ribosylation: a histone shuttle mechanism in DNA excision repair J Cell Sci 102 1992 663 670
126. A. Ivana Scovassi, and M. Diederich Modulation of poly(ADP-ribosylation) in apoptotic cells Biochem Pharmacol 68 2004 1041 1047
127. A. Saija, R. De Pasquale, and G. Costa Cholinomimetic drugs modify betamethasone suppression in the rat Pharmacol Res 21 1989 609 616
128. S. Demissie, V.K. Ghanta, N.S. Hiramoto, and R.N. Hiramoto NK cell and CTL activities can be raised via conditioning of the CNS with unrelated unconditioned stimuli Int J Neurosci 103 2000 79 89
129. T.Z. Su, K.L. Chang, C.H. Lee, C.H. Chen, Y.H. Yang, and T.Y. Shieh Expression of tumor necrosis factor-alpha and its soluble receptors in betel-quid-chewing patients at different stages of treatment for oral squamous cell carcinoma Oral Oncol 40 2004 804 810
130. M.F. Haque, S. Meghji, U. Khitah, and M. Harris Oral submucous fibrosis patients have altered levels of cytokine production J Oral Pathol Med 29 2000 123 128
131. P. Balaram, M.R. Pillai, and T. Abraham Immunology of premalignant and malignant conditions of the oral cavity. II. Circulating immune complexs J Oral Pathol 16 1987 389 391
132. P. Remani, R. Ankathil, K.K. Vijayan, V.M. Haseena Beevi, R. Rajendran, and T. Vijayakumar Circulating immune complexes as an immunological marker in premalignant and malignant lesions of the oral cavity Cancer Lett 40 1988 185 191
133. F.A. Salinas, and K.H. Wee Immune complexes and neoplasia Biomed Pharmacother 37 1983 119 125
134. J.P. Canniff, W. Harvey, and M. Harris Oral submucous fibrosis: its pathogenesis and management Br Dent J 160 1986 429 434
135. A.N. Houghton, and J.A. Guevara-Patino Immune recognition of self in immunity against cancer J Clin Invest 114 2004 468 471
136. K. Ishihara, and T. Hirano IL-6 in autoimmune disease and chronic inflammatory proliferative disease Cytokine Growth Factor Rev 13 2002 357 368
137. M. Abu-Shakra, D. Buskila, M. Ehrenfeld, K. Conrad, and Y. Shoenfeld Cancer and autoimmunity: autoimmune and rheumatic features in patients with malignancies Ann Rheum Dis 60 2001 433 441
138. S. Yasumura, E. Weidmann, H. Hirabayashi, J.T. Johnson, R.B. Herberman, and T.L. Whiteside HLA restriction and T-cell-receptor Vβ gene expression of cytotoxic T lymphocytes reactive with human squamous cell carcinoma of the head and neck Int J Cancer 57 1994 297 305
139. M. Sato, H. Yoshida, T. Yanagawa, Y. Yura, M. Urata, and M. Atsumi Effect of intradermal administration of streptococcal preparation OK-432 on interferon and natural killer cell activities in patients with oral cancer Int J Oral Surg 13 1984 7 15
140. T.L. Whiteside, E. Letessier, H. Hirabayashi, D. Vitolo, J. Bryant, and L. Barnes Evidence for local and systemic activation of immune cells by peritumoral injection of interleukin-2 in patients with advanced squamous cell carcinoma of the head and neck Cancer Res 53 1993 5654 5662
141. + co-stimulatory molecule and interferon-γ Int J Cancer 86 2000 368 374
142. S.P. Rashleigh, D.I. Kusher, J.N. Endicott, A.R. Rossi, and J.Y. Djeu Interleukins 2 and 12 activate natural killer cytolytic responses of peripheral blood mononuclear cells from patients with head and neck squamous cell carcinoma Arch Otolaryngol Head Neck Surg 122 1996 541 547
143. J.W. Hadden The immunopharmacology of head and neck cancer: An update Int J Immunopharmacol 19 1997 629 644
144. M.C. Chang, H.L. Wu, J.J. Lee, P.H. Lee, H.H. Chang, and L.J. Hahn The induction of prostaglandin E2 production, interleukin-6 production, cell cycle arrest and cytotoxicity in primary oral keratinocytes and KB cancer cells by areca nut ingredients is differentially regulated by MEK/ERK activation J Biol Chem 279 2004 50676 50683
145. F. Belardelli, and M. Ferrantini Cytokines as a link between innate and adaptive antitumor immunity Trends Immunol 23 2002 201 208
146. K.J. Malmberg Effective immunotherapy against cancer: A question of overcoming immune suppression and immune escape? Cancer Immunol Immunother 53 2004 879 892
147. H. Ohshima, M. Tatemichi, and T. Sawa Chemical basis of inflammation-induced carcinogenesis Arch Biochem Biophys 417 2003 3 11
148. K.E. Driscoll TNFalpha and MIP-2: role in particle-induced inflammation and regulation by oxidative stress Toxicol Lett 112-113 2000 177 183
149. S. Diehl, and M. Rinson The two faces of IL-6 on Th1/Th2 differentiation Mol Immunol 39 2002 531 536
150. N. Mukaida Interleukin-8: an expanding universe beyond neutrophil chemotaxis and activation Int J Hematol 72 2000 391 398
151. D.Z. Chang, W. Lomazow, C. Joy Somberg, R. Stan, and M.A. Perales Granulocyte-macrophage colony stimulating factor: an adjuvant for cancer vaccines Hematology 9 2004 207 215
152. S. Zhang, and T.M. Petro The effect of nicotine on murine CD4 T cell responses Int J Immunopharmacol 18 1996 467 478
153. G.R. Thomas, Z. Chen, E. Leukinova, C. Van Waes, and J. Wen Cytokines IL-1 alpha, IL-6 and GM-CSF constitutively secreted by oral squamous carcinoma induce down-regulation of CD80 costimulatory molecule expression: restoration by interferon gamma Cancer Immunol Immunother 53 2004 33 40
154. S.J. Pettit, K. Seymour, E. O'Flaherty, and J.A. Kirby Immune selection in neoplasia: towards a microevolutionary model of cancer development Br J Cancer 82 2000 1900 1906
155. G.T. Wolf, J.L. Hudson, K.A. Peterson, H.L. Miller, and K.D. McClatchey Lymphocyte subpopulations infiltrating squamous carcinoma of the head and neck: correlations with extent of tumor and prognosis Otolaryngol Head Neck Surg 95 1986 142 152